Growth and endocrine function in steroid sensitive nephrotic syndrome
- PMID: 3133989
- PMCID: PMC1778944
- DOI: 10.1136/adc.63.5.484
Growth and endocrine function in steroid sensitive nephrotic syndrome
Abstract
Longitudinal height data and physical development were assessed in 29 boys and 12 girls taking long term steroid treatment for steroid sensitive nephrotic syndrome. Growth in both boys and girls, assessed by changes in height standard deviation score (delta Ht SDS), worsened significantly with chronological age. There was a significant negative correlation between delta Ht SDS and duration of treatment in boys, but not in girls. There was no correlation between delta Ht SDS and relapse rate or the use of cyclophosphamide. In the boys, Ht SDS decreased significantly only after the age of 10 years and was associated with delay in the appearance of secondary sexual characteristics. Eight adolescent boys were assessed endocrinologically by an overnight hormone profile. Blunting of the pulsatility of growth hormone and gonadotrophins was seen in six. Normal profiles were seen in two subjects who were both off steroid treatment at the time of study. Abnormal endocrine function in adolescent boys treated long term for steroid sensitive nephrotic syndrome corresponded with the clinical picture of delayed onset of puberty, which accounted for severe growth retardation in a substantial proportion of subjects.
Similar articles
-
Final height in children with steroid-sensitive nephrotic syndrome.Pediatr Int. 2007 Oct;49(5):623-5. doi: 10.1111/j.1442-200X.2007.02429.x. Pediatr Int. 2007. PMID: 17875088
-
Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.Arch Dis Child. 2010 Feb;95(2):146-9. doi: 10.1136/adc.2007.129957. Arch Dis Child. 2010. PMID: 20172895
-
Growth and endocrine function after renal transplantation.Arch Dis Child. 1988 Nov;63(11):1326-32. doi: 10.1136/adc.63.11.1326. Arch Dis Child. 1988. PMID: 3060022 Free PMC article.
-
Disorders of Puberty: An Approach to Diagnosis and Management.Am Fam Physician. 2017 Nov 1;96(9):590-599. Am Fam Physician. 2017. PMID: 29094880 Review.
-
Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.Pediatr Nephrol. 2005 Oct;20(10):1376-81. doi: 10.1007/s00467-005-1964-z. Epub 2005 Jun 24. Pediatr Nephrol. 2005. PMID: 15977023 Review.
Cited by
-
Final height of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome.Pediatr Nephrol. 2009 Dec;24(12):2401-8. doi: 10.1007/s00467-009-1301-z. Pediatr Nephrol. 2009. PMID: 19816715
-
Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.Pediatr Nephrol. 2004 Apr;19(4):400-7. doi: 10.1007/s00467-003-1378-8. Epub 2004 Feb 26. Pediatr Nephrol. 2004. PMID: 14991389
-
Haemostatic profile of children with nephrotic syndrome attending University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria.BMC Nephrol. 2022 Aug 4;23(1):274. doi: 10.1186/s12882-022-02894-5. BMC Nephrol. 2022. PMID: 35927678 Free PMC article.
-
Dietary management in nephrotic syndrome.Arch Dis Child. 1993 Aug;69(2):179-80. doi: 10.1136/adc.69.2.179. Arch Dis Child. 1993. PMID: 8215516 Free PMC article. No abstract available.
-
Pubertal development in children with chronic kidney disease.Pediatr Nephrol. 2017 Jun;32(6):949-964. doi: 10.1007/s00467-016-3432-3. Epub 2016 Jul 27. Pediatr Nephrol. 2017. PMID: 27464647 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical